Objectives: The aim of this study was to investigate different hydrophobic gentamicin formulations: gentamicin-bis(2-ethylhexyl) sulfosuccinate (GEN-AOT), microstructured GEN-AOT (PCA GEN-AOT) and GEN-AOT loaded poly(lactid-co-glycolic) acid (PLGA) nanoparticles (NPs) in view of improving its therapeutic index against intracellular bacteria. The intracellular accumulation, subcellular distribution and intracellular activity of GEN-AOT and NPs in different monocytic-macrophagic cell lines were studied. 
INTRODUCTION
Despite their high bactericidal character, aminoglycoside antibiotics are considered as poorly active against intracellular bacteria, 1, 2 which has been attributed to their inappropriate cellular pharmacokinetic profile. Because of their high hydrophilicity, aminoglycosides only penetrate slowly cells and, once inside them, remain confined in the lysosomal compartment, where their activity is reduced by the acidic pH. 3 Considerable efforts are therefore made to enhance their cellular concentration.
Drug delivery system (DDS)-based approaches are being explored in this context. 4 Although they have shown very promising results, in vivo stability and drug loading efficiency in the carriers remain however important issues. A new approach consists in the chemical modification of gentamicin with the anionic surfactant bis(2-ethylhexyl) sulfosuccinate sodium salt (AOT) (GEN-AOT) and its micronization by precipitation through a compressed fluid-based methodology (Precipitation with a Compressed Antisolvent, PCA) to obtain a microstructured GEN-AOT (PCA GEN-AOT), or incorporation in poly(lactid-co-glycolic) (PLGA) nanoparticles (NPs) with a very high encapsulation efficiency. 5 We have compared here the cellular pharmacokinetics and pharmacodynamics of these new formulations using bacteria sojourning in different intracellular locations, namely Staphylococcus aureus (phagolysosomal) and Listeria monocytogenes (cytoplasmic).
MATERIALS AND METHODS

Materials
Gentamicin sulphate and Bis(2-ethylhexyl) sulfosuccinate sodium salt (AOT) were purchased 
Preparation of gentamicin-AOT, microstructured gentamicin-AOT and gentamicin-AOT nanoparticles
All gentamicin formulations were prepared as previously described. Figure 1 in Supplemental Material; assays used:
release of the cytoplasmic enzyme lactate dehydrogenase in the culture medium (LDH assay) 7 and formation of blue formazan crystals by mitochondrial dehydrogenases in metabolically-active cells (MTT assay) 8 ).
Cellular accumulation and fractionation studies
The cellular accumulation of the antibiotic formulations was studied in THP-1 cells, A-THP-1 cells and J774 cells as previously reported. 9, 10 Their subcellular distribution was studied in J774 cells after 24 h of incubation using the cell fractionation procedure described previously.
11
Gentamicin content was quantified by microbiological assay using antibiotic medium 11 and
Bacillus subtilis ATCC 6633 as test organism (limit of detection 0.125 mg/L, linear response between 0.125 and 64 mg/L, R 2 0.989) 7 and expressed by reference to the total cell protein content (determined by the Lowry method). Cellular accumulation was estimated using a conversion factor of 5 μL cell volume/mg of cell protein.
12, 13
Bacterial strains, susceptibility testing and cell infection studies 
Statistical analysis
Data analysis and graphical presentation were performed using GraphPad Prism version 5.00
(GraphPad Software, San Diego, CA, USA). Statistical comparison between different groups was performed using Mann-Whitney U test.
RESULTS AND DISCUSSION
Micronized gentamicin-AOT and gentamicin-AOT polymeric nanoparticles (NP)
Micronization of GEN-AOT (PCA GEN-AOT) resulted in a powdered solid with a mean diameter of 1 μm and a zeta potential of around -1 mV. GEN-AOT loaded PLGA 502H and PLGA 752H
NPs presented mean diameters of 263 ± 10 nm and 269 ± 24 nm and a zeta potential of -3.3 ± 0.5 mV and -3.5 ± 0.9 mV, respectively. Encapsulation efficiencies of 100 % were achieved for both NP formulations with drug loadings of 21.9 ± 0.5 and 22.7 ± 0.7 μg gentamicin/mg of NP for PLGA 502H and PLGA 752H NPs, respectively.
Kinetics of cellular accumulation
The cellular uptake of gentamicin has been extensively studied in different cell lines and conditions, 3 and was found to be low in phagocytic cells. 16 We therefore firstly exposed cells for with the rate of uptake of horseradish peroxydase, a fluid phase endocytosis tracer, in J774 macrophages 10 and is coherent with the mechanism of pinocytosis proposed to explain gentamicin slow accumulation. 13, 18 Non-encapsulated GEN-AOT also followed a linear kinetics of accumulation. Yet, its rate of uptake was 1.5 to 2-fold higher ( Figure 1 , panel C). This could be attributed to the lower charge of the ion pair, which would increase the partition coefficient of gentamicin, as reported for cisplatin 19 and for antibiotics such as ampicillin and erythromycin. [20] [21] [22] The grossly linear kinetics of uptake of GEN-AOT could fit with this model, but could also result from a slow endocytic process for which the plateau of accumulation has not yet been reached, as is the case for gentamicin. Incorporation of GEN-AOT into polymeric NPs further increased both antibiotic uptake rate and efficiency, especially for NPs formulated with 752H, the more hydrophobic PLGA copolymer. It is known that uptake of particles by phagocytic cells is critically dependent on their physico-chemical properties. 23 For PLGA particles, it is inversely related to polymer hydrophilicity. 24, 25 GEN-AOT 752H NPs allowed gentamicin to accumulate more than 10-fold in both macrophage cell lines (see Figure 2 in supplemental material for accumulation factors of the different formulations at 24h). This rate of uptake remains about 10 times lower than that of the lipoglycopeptide antibiotic oritavancin, which is thought to enter cells by adsorptive endocytosis, 10 suggesting that binding at the cell surface are probably different.
Subcellular distribution of gentamicin and gentamicin-AOT formulations
Cellular accumulation per se is not always predictive of antibiotic intracellular efficacy notably because the drug also needs to reach in sufficient amount the infected compartment. 26, 27 Figure   2 shows the subcellular distribution of the formulations together with those of the marker enzymes cytochrome c oxidase (for mitochondria), N-acetyl-β-glucosaminidase (for lysosomes) and lactate dehydrogenase (for soluble proteins) in the control cells. No differences were found in subcellular distribution profile of the markers in non-treated and treated J774 cells, indicating that the treatments did not affect the biophysical properties and integrity of the studied organelles or the distribution of the soluble proteins (data not shown). As expected from its lysosomotropic nature, gentamicin showed a subcellular distribution that was very close to that of N-acetyl-β-glucosaminidase, predominantly localized in the granular fraction (77% of cellassociated drug). This intracellular disposition is not specific to macrophages as it is also reported in other non-phagocytic cell lines, [28] [29] [30] [31] and is thought to be, together with the decreased activity of gentamicin at acidic pH, the responsible of the its low efficacy against a number of intracellular bacteria. 1, 32, 33 Interestingly, ion pairing and encapsulation processes altered the distribution profile of gentamicin inside the cells and allowed for a higher accumulation in their soluble fraction (containing the cytosol and the soluble proteins). Thus, in cells incubated with GEN-AOT, 45% of cell-associated drug was recovered in the soluble fraction, leading to a 25-fold increase in gentamicin accumulation in this fraction. Again, this could be explained by the non-ionized character of GEN-AOT, which could facilitate the translocation of the drug from the lysosomes to the cytoplasm or its diffusion through the pericellular membrane. In cells incubated with PLGA 502H and 752H NPs, the accumulation of gentamicin was 2 to 3-fold higher in the organelles and 74 to 124-fold higher in the soluble fraction than in cell exposed to free gentamicin. It has been proposed that the acidic pH of lysosomes may cause an inversion of NP surface charge, which may favour the interaction of NP with the lysosomal membrane and facilitate their escape into cytosol.
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Antibiotic susceptibility studies and effect of acidic pH MIC and MBC values of gentamicin and its formulations are shown in Table S Supplementary material: Results are expressed as the MIC in mg/L of antibiotic.
